Regencell Bioscience Lim...

NASDAQ: RGC · Real-Time Price · USD
12.93
0.23 (1.81%)
At close: Aug 15, 2025, 3:03 PM

Regencell Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cash & Equivalents
2.96M 2.96M 4.8M 4.8M 1.56M 1.56M n/a n/a 6.42M 6.42M n/a n/a 59.41K 59.41K 305.96K 305.96K
Short-Term Investments
5M 5M n/a n/a 10M 10M n/a n/a 10M 10M n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
97.68K 97.68K 642.42K 642.42K 108.5K 108.5K 1.36M 1.36M 114.3K 114.3K 2.05M 2.05M 191.42K 191.42K 184.16K 184.16K
Receivables
152.78K n/a n/a n/a 56.55K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a -56.55K n/a n/a n/a -27.6K n/a n/a n/a -7.44K n/a n/a n/a
Other Current Assets
n/a -0.00 5.03M 5.03M n/a 56.55K 14.19M 14.19M 0.00 0.00 19.01M 19.01M n/a n/a n/a n/a
Total Current Assets
8.11M 8.11M 9.83M 9.83M 11.62M 11.62M 14.19M 14.19M 16.44M 16.44M 19.01M 19.01M 66.85K 66.85K 305.96K 305.96K
Property-Plant & Equipment
226.51K 226.51K n/a n/a 891.91K 891.91K n/a n/a 1.46M 1.46M n/a n/a 81.86K 81.86K 110.26K 110.26K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
324.2K 324.2K 642.42K 642.42K 1M 1M 1.36M 1.36M 1.57M 1.57M 2.05M 2.05M 273.29K 273.29K 294.42K 294.42K
Total Assets
8.44M 8.44M 10.48M 10.48M 12.62M 12.62M 15.55M 15.55M 18.02M 18.02M 21.06M 21.06M 340.13K 340.13K 600.37K 600.37K
Account Payables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.36K 1.36M 3.68M 3.68M 3.54M 3.54M
Other Current Liabilities
n/a 8.44K n/a n/a n/a 10.57K n/a n/a n/a 15.65K -1.36K n/a n/a 82.81K n/a 0.00
Total Current Liabilities
193.58K 193.58K n/a n/a 606.91K 606.91K n/a n/a 577.76K 577.76K 1.36K 1.36M 4.34M 4.34M 3.59M 3.59M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 312.55K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
25.93K 25.93K 312.55K 312.55K 25.41K 25.41K 873.79K n/a 360.27K 360.27K n/a n/a n/a n/a n/a n/a
Total Liabilities
219.51K 219.51K 312.55K 312.55K 632.32K 632.32K 873.79K n/a 938.03K 938.03K 1.36M 1.36M 4.34M 4.34M 3.59M 3.59M
Total Debt
85.74K 85.74K n/a n/a 463.67K 25.41K n/a n/a 771.25K 360.27K 1.36K 1.36M 3.68M 3.68M 3.54M 3.54M
Common Stock
130.00 130.00 10.16M 10.16M 130.00 130.00 14.67K 14.67M 130.00 130.00 19.7K 19.7M 100.00 100.00 100.00 100.00
Retained Earnings
-21.62M -21.62M n/a n/a -17.32M -17.32M n/a n/a -11.44M -11.44M n/a n/a -4M -4M -2.99M -2.99M
Comprehensive Income
-45.77K -45.77K n/a n/a -86.66K -86.66K n/a n/a 0.00 0.00 n/a n/a n/a n/a -22.85K n/a
Shareholders Equity
8.22M 8.22M 10.16M 10.16M 12.03M 12.03M 14.66M 14.67M 17.07M 17.07M 19.7M 19.7M -4M -4M -2.98M -2.98M
Total Investments
5M 5M n/a n/a 10M 10M n/a n/a 10M 10M n/a n/a n/a n/a n/a n/a